Recent innovations across the multiple ADC components, such as enhanced antibody-targeting to the tumors, better linker ...

In this video, Sonali M. Smith, MD, discusses several notable studies on new treatment combinations and other options for ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

NextCure has ramped up its antibody-drug conjugate (ADC) pivot, penning a $745 million deal for the ex-China rights to ...

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...

The companies aim to generate preclinical proof-of-concept data on SRB123 and quickly take it into clinical trials.

Analysis of Antibody Drug Conjugates Contract Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan ROCKVILLE, MD, UNITED STATES, June 18, ...

Medicovestor and Sanyou Biopharmaceuticals signed a strategic partnership agreement, witnessed by Medicovestor COO Lin Ong; ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Avidity has been given the go-ahead by the FDA to request accelerated approval of delpacibart braxlosiran—potentially the ...